CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-29 | PAPA JOSEPH C President and CEO | Grant or award | +187,708 | 493,153 | ||
| 2026-03-05 | PAPA JOSEPH C President and CEO | Shares withheld for taxes | −37,055 | $8.44 | $313K | 305,445 |
| 2026-03-03 | PAPA JOSEPH C President and CEO | Grant or award · Employee Stock Option (Right to buy) | +252,194 | 1,784,694 | ||
| 2025-05-13 | PAPA JOSEPH C President and CEO | Purchase | +60,000 | $5.83 | $350K | 342,500 |
| 2025-03-12 | PAPA JOSEPH C President and CEO | Grant or award · Employee Stock Options (Right to Buy) | +250,000 | 1,282,500 | ||
| 2025-03-12 | PAPA JOSEPH C President and CEO | Grant or award · Employee Stock Options (Right to Buy) | +250,000 | 1,532,500 | ||
| 2025-03-06 | PAPA JOSEPH C President and CEO | Grant or award | +282,500 | 282,500 | ||
| 2025-03-06 | PAPA JOSEPH C President and CEO | Grant or award · Employee Stock Options (Right to Buy) | +282,500 | 1,032,500 | ||
| 2024-03-13 | PAPA JOSEPH C President and CEO | Grant or award · Employee Stock Options (Right to Buy) | +750,000 | 750,000 |
Page 1 of 1 · 9 trades